This brand name is authorized in United States
The drug PRETOMANID contains one active pharmaceutical ingredient (API):
1
Pretomanid
UNII 2XOI31YC4N - PRETOMANID
|
Pretomanid is a nitroimidazooxazine antimycobacterial drug. It is used as part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug resistant (XDR) or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB). |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PRETOMANID Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: US | FDA, National Drug Code | Identifier(s): 49502-476 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.